FindTrial
Sign In

To study the effect of Dexmedetomidine when used as an adjuvant to 0.5% Bupivacaine in Brachial plexus block

Effect of Dexmedetomidine as an adjuvant to 0.5% Bupivacaine in Brachial plexus block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028887
Enrollment
64
Registered
2020-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S559- Injury of unspecified blood vesselat forearm level Health Condition 2: S614- Open wound of hand Health Condition 3: S615- Open wound of wrist Health Condition 4: S698- Other specified injuries of wrist,hand and finger(s) Health Condition 5: S529- Unspecified fracture of forearm Health Condition 6: S629- Unspecified fracture of wrist andhand

Interventions

Control Intervention1: Bupivacaine 0.5% 20mL Dexmedetomidine 50mcg: Bupivacaine - Local anaesthetic Dexmedetomidine - Adjuvant Control Intervention2: Bupivacaine 20mL 0.5% Normal saline 1ml: Bupivacai

Sponsors

Merin Helen Mathai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 patients Patients undergoing forearm and hand surgeries

Exclusion criteria

Exclusion criteria: Patients with neurological and neuromuscular disorder Brachial plexus injury SENSITIVE OR ALLERGIC TO STUDY MEDICATION Clotting disorder Local infection Pregnancy Patient refusal

Design outcomes

Primary

MeasureTime frame
Onset and duration of sensory and motor blockTimepoint: Onset and duration of sensory and motor block—

Secondary

MeasureTime frame
Pulse rate Systolic blood pressure Diastolic blood pressure Mean arterial pressureTimepoint: Baseline parameters Every 5 mins from initiation of block upto 30 mins thereafter every 10 mins till the block wean off—

Countries

India

Contacts

Public ContactDr Merin Helen Mathai

Pushpagiri institute of medical sciences and research centre

drmaryalbert@gmail.com9495685155

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026